Pangaea Data Awarded Top Tier Co-Sell Partnership Status by Microsoft

Pangaea Named ‘Digital Solution of the Year’ by UK Government’s Department for International Trade

Global Pharmaceutical Proves Pangaea’s AI

Go back

“Characterising Patients by Mapping their Journeys & Disease Trajectories in a Privacy-Preserving & Scalable Manner”

1:15 - 2:00PM GMT, Luncheon Presentation, January 25th, London, UK

Venue: Business Design Centre, London, UK

Presentation: Characterising Patients by Mapping their Journeys & Disease Trajectories in a Privacy-Preserving & Scalable Manner

This luncheon presentation will demonstrate how Pangaea’s AI-driven product, PIES, characterises patients by mapping their journey across hard-to-diagnose conditions by discovering clinically actionable intelligence from their records in a scalable, evolving and privacy-preserving manner. This is helping global pharmaceutical and healthcare providers discover new intelligence; 20x more patients in the context of early diagnosis, clinical trials, new therapies; and reduced treatment costs by 50% in only 4-6 weeks, saving 90% in operational costs and time.

This luncheon presentation is by invitation only. To register your interest, please contact us at info@pangaeadata.ai or register through the link below.

Schedule a Meeting


Presenters

Dr. Vibhor Gupta
Director & Founder
Pangaea Data
Dr. Jingqing Zhang
Head of AI
Pangaea Data